Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dimerix Limited ( (AU:DXB) ) has issued an update.
Dimerix Limited has announced the quotation of 948,636 fully paid ordinary securities on the Australian Securities Exchange (ASX) under the code DXB. This move follows the exercise of options or conversion of other convertible securities, potentially enhancing the company’s liquidity and market presence.
More about Dimerix Limited
Dimerix Limited operates in the biotechnology industry, focusing on the development of pharmaceutical products. The company is primarily engaged in creating therapies for unmet medical needs, particularly in the field of kidney diseases.
Average Trading Volume: 2,926,851
Technical Sentiment Signal: Buy
Current Market Cap: A$371.9M
See more insights into DXB stock on TipRanks’ Stock Analysis page.